Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China
· Delayed Price · Currency is CNY 14.01
+0.12 (0.86%)
At close: Mar 10, 2026
SHE:002275 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 522.88 | 521.53 | 421.3 | 329.53 | 343.72 | 277.02 | Upgrade
|
| Depreciation & Amortization | 106.45 | 106.45 | 115.12 | 114.83 | 106.72 | 80.27 | Upgrade
|
| Other Amortization | 20.04 | 20.04 | 9.61 | 9.21 | 6.27 | 2.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -83.35 | -83.35 | -1.67 | -31.24 | -15.12 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 1 | 7.74 | 1.71 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.99 | -9.99 | -6.57 | -5.87 | -9.65 | 1.37 | Upgrade
|
| Provision & Write-off of Bad Debts | 9.22 | 9.22 | 0.01 | 3.91 | 1.28 | -2.78 | Upgrade
|
| Other Operating Activities | 223.47 | 26.97 | 16.73 | 8.71 | 18.05 | -1.81 | Upgrade
|
| Change in Accounts Receivable | -71.56 | -71.56 | 72.95 | -88.25 | -66.83 | 108.49 | Upgrade
|
| Change in Inventory | 20.54 | 20.54 | -27.23 | 33.67 | -99.73 | -18.43 | Upgrade
|
| Change in Accounts Payable | 46.36 | 46.36 | -80.35 | 84.98 | 120.16 | 148.37 | Upgrade
|
| Change in Other Net Operating Assets | 2.85 | 2.85 | 30.48 | 65.78 | - | - | Upgrade
|
| Operating Cash Flow | 786.18 | 588.33 | 549.25 | 528.67 | 410.24 | 597.99 | Upgrade
|
| Operating Cash Flow Growth | 42.27% | 7.12% | 3.89% | 28.87% | -31.40% | 27.70% | Upgrade
|
| Capital Expenditures | -206.68 | -82.18 | -76.4 | -62.27 | -144.09 | -205.47 | Upgrade
|
| Sale of Property, Plant & Equipment | -1.24 | 0.46 | 53.69 | 2.75 | 27.73 | 7.2 | Upgrade
|
| Investment in Securities | 62.1 | 99.59 | 473.49 | 957.69 | -39.94 | -23.44 | Upgrade
|
| Other Investing Activities | -417.39 | -367.29 | -545.01 | -978.43 | 9.33 | 13.75 | Upgrade
|
| Investing Cash Flow | -563.22 | -349.41 | -94.22 | -80.24 | -146.97 | -207.96 | Upgrade
|
| Long-Term Debt Issued | - | 476.7 | 410.7 | 159.7 | 276.68 | 318.74 | Upgrade
|
| Total Debt Issued | 548.58 | 476.7 | 410.7 | 159.7 | 276.68 | 318.74 | Upgrade
|
| Long-Term Debt Repaid | - | -398.98 | -354.24 | -315.71 | -192.87 | -116.03 | Upgrade
|
| Total Debt Repaid | -430.9 | -398.98 | -354.24 | -315.71 | -192.87 | -116.03 | Upgrade
|
| Net Debt Issued (Repaid) | 117.68 | 77.72 | 56.46 | -156.01 | 83.81 | 202.71 | Upgrade
|
| Issuance of Common Stock | - | - | - | 84.1 | - | - | Upgrade
|
| Common Dividends Paid | -362.89 | -336.14 | -427.77 | -570.88 | -453.7 | -146.73 | Upgrade
|
| Other Financing Activities | 52.79 | 50.11 | 9.74 | -40 | 50 | -137.88 | Upgrade
|
| Financing Cash Flow | -192.42 | -208.31 | -361.57 | -682.78 | -319.89 | -81.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.71 | 1.06 | 0.86 | 8.31 | -2.71 | -1.13 | Upgrade
|
| Net Cash Flow | 32.25 | 31.68 | 94.32 | -226.04 | -59.33 | 307.01 | Upgrade
|
| Free Cash Flow | 579.5 | 506.16 | 472.85 | 466.4 | 266.15 | 392.52 | Upgrade
|
| Free Cash Flow Growth | 19.10% | 7.04% | 1.38% | 75.24% | -32.19% | 62.10% | Upgrade
|
| Free Cash Flow Margin | 27.84% | 23.07% | 21.77% | 23.80% | 15.29% | 25.06% | Upgrade
|
| Free Cash Flow Per Share | 1.00 | 0.86 | 0.81 | 0.79 | 0.47 | 0.68 | Upgrade
|
| Cash Income Tax Paid | 369.36 | 334.58 | 389.12 | 251.67 | 247.99 | 237.78 | Upgrade
|
| Levered Free Cash Flow | 270.86 | 291.64 | 349.37 | 249.38 | 156.13 | 351.23 | Upgrade
|
| Unlevered Free Cash Flow | 276.36 | 300.29 | 359.59 | 262.03 | 167.51 | 358.46 | Upgrade
|
| Change in Working Capital | -2.53 | -2.53 | -5.28 | 98.6 | -48.77 | 240.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.